FDA Drug Safety Podcast: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease
Listen to an audio podcast of the February 22, 2018 FDA Drug Safety Communication: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease. As a result, we have added a new warning about this increased risk of death in patients with heart disease, and advised prescribers to consider using other antibiotics in such patients (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
March 2, 2018 This Week in Cardiology
Vegetarian vs Mediterranean diets, a clarithromycin alert, a new stent, best choice of IV fluid, and early work in prevention Type I diabetes are discussed in this week ' s podcast. (Source: Medscape Cardiology Podcast)
Source: Medscape Cardiology Podcast - March 2, 2018 Category: Cardiology Authors: Medscape Source Type: podcasts
FDA Drug Safety Podcast: FDA review finds additional data supports the potential for increased long-term risks with antibiotic clarithromycin (Biaxin) in patients with heart disease
On February 22, 2018, FDA advised caution before prescribing the antibiotic clarithromycin (brand name Biaxin) to patients with heart disease because of a potential increased risk of heart problems or death that can occur years later. (Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - February 26, 2018 Category: Drugs & Pharmacology Authors: U.S. Food and Drug Administration, Center for Drug Evaluation and Research Source Type: podcasts
JAMA 2013-12-17, Vol. 310, No. 23, Author Audio Interview
Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker–Clarithromycin Drug Interactions and Acute Kidney Injury (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 17, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury
Interview with Amit X. Garg, MD, PhD, author of Calcium-Channel Blocker-Clarithromycin Drug Interactions and Acute Kidney Injury (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 17, 2013 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
